Arcus Biosciences Inc (NYSE:RCUS)

31.30
Delayed Data
As of Apr 09
 +0.40 / +1.29%
Today’s Change
14.89
Today|||52-Week Range
42.36
+20.57%
Year-to-Date
No recent news for Arcus Biosciences Inc.

Today’s Trading

Previous close30.90
Today’s open31.30
Day’s range30.68 - 31.92
Volume316,144
Average volume (3 months)518,161
Market cap$2.2B
Data as of 4:00pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)-16.02%
Earnings growth (this year)-35.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+416.78%
P/E ratioNM
Price/Sales18.35
Price/Book4.06

Competitors

----
MORFMorphic Holding Inc-1.77-2.90%
SRNESorrento Therapeutic...-0.24-3.10%
RUBYRubius Therapeutics ...-0.18-0.75%
Data as of 5:30pm ET, 04/09/2021

Financials

Next reporting dateMay 12, 2021
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$77.5M
Annual profit (last year)-$122.9M
Net profit margin-158.49%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Hayward, California

Forecasts